Cardiac Amyloidosis

Cardiac Amyloidosis

Cardiac Amyloidosis

Course Director(s): Martha Grogan, M.D.

Released On: March 15, 2014 - Length: 42:41

Add to Cart

$40-$50

Overview

slide

Cardiac amyloidosis is an important cause of restrictive cardiomyopathy and is not as rare as previously reported. Transthyretin cardiac amyloidosis is an under-recognized cause of heart failure in middle-aged and elderly men and in blacks. Treatment is now available for all types of cardiac amyloidosis and is rapidly evolving. Delayed diagnosis continues to be a major determinant of poor prognosis. This tutorial will review the three most types of amyloid that involve the heart. The state-of-the art approach to diagnosis and management of cardiac amyloidosis will be discussed.

Objectives

  • Recognize the types of amyloid that affect the heart and the clinical characteristics of each type
  • Summarize the appropriate diagnostic evaluation for suspected cardiac amyloidosis
  • Demonstrate an understanding of the treatment options for patients with cardiac amyloidosis

Faculty


Martha Grogan, M.D., FACC

Assistant Professor of Medicine
Director Cardiac Amyloid Clinic
Division of Cardiovascular Disease and Internal Medicine
Mayo Clinic, Rochester, MN

Pricing

$40 - Streaming Video

$50 - Streaming Video and DVD

Purchase Options


Choose your preferred method

50.00

DVD & Online Video

Add to Cart

40.00

Online Video Only

Add to Cart

Recently Viewed

slide

Product Available

$40-$50

 
Date: 3/15/2014 - 3/15/2018

Refer a Patient

Arizona: 866-629-6362

Florida: 800-634-1417

Minnesota: 800-533-1564


Back to top